Women’s Cancers and Supportive Care

• Opening Remarks

  Robert J. Mayer MD – Course Director

Women’s Cancers

Track Leader: Dr. Burstein

• Molecular Advances and Emerging Treatment Strategies in Ovarian and Endometrial Cancers

  Ursula A. Matulonis MD

• HER2-Positive and Triple-Negative Breast Cancers: An Evolving Treatment Landscape

  Eric P. Winer MD

• Advances in Hormone Receptor Positive Breast Cancer and Hereditary Breast Cancer Syndromes

  Harold J. Burstein MD, PhD

• Session Break

Supportive Care

Moderator: Dr. Burstein

• Supportive and Palliative Care: Managing Symptoms and Toxicities to Improve Patient Outcomes

  Janet L. Abrahm MD

• Optimizing Outcomes for Survivors of Cancer

  Ann H. Partridge MD, MPH

• Panel Discussion

  All Faculty

• Closing Remarks

Hematologic Malignancies

• Opening Remarks

  Robert J. Mayer MD – Course Director

Hematologic Malignancies

Moderator: Dr. Connors

• Non-Hodgkin and Hodgkin Lymphoma: An Individualized Treatment Approach

  Ann S. LaCasce MD, MMSC

• Myeloid Malignancies: Molecular Markers and Targeted Therapies

  Richard M. Stone MD

• Molecular Drivers of Myeloproliferative Neoplasms: Impact on Diagnosis, Assessment, and Management

  Ayalew Tefferi MD

• Multiple Myeloma: Current Evidence-Based Management

  Kenneth C. Anderson MD

• Session Break

• Chronic Lymphocytic Leukemia: Evaluating the Rapidly Changing Treatment Landscape

  John C. Byrd MD

• Cancer Associated Venous Thromboembolic Disease: Current Guidance and Clinical Data

  Jean M. Connors MD

• Panel Discussion

  All Faculty

• Closing Remarks

Gastrointestinal Cancer and Sarcoma

• Opening Remarks

  Robert J. Mayer MD – Course Director

Sarcoma

Moderator: Dr. Mayer

• Best Practices and Expanding Treatment Options in Soft Tissue Sarcoma

  George D. Demetri MD

Gastrointestinal Cancers

Moderator: Dr. Mayer

• Novel Approaches for the Management of Esophageal, Gastric, and Pancreatic Cancers

  Peter C. Enzinger MD

• Hereditary Gastrointestinal Cancers: From Family History to Management with Combination Therapy

  Matthew B. Yurgelun MD

• Session Break

• Reducing Risk: Current Clinical Evidence on Lifestyle Management and Chemopreventative Agents in Gastrointestinal Cancer

  Charles S. Fuchs MD, MPH

• Colorectal Cancer: Molecular Markers and Evidence-Based Best Practices for Systemic Treatment

  Robert J. Mayer MD

• Panel Discussion

  All Faculty

• Closing Remarks

Head, Neck and Lung Cancers and Melanoma Cancer

• Opening Remarks

  Robert J. Mayer MD – Course Director

Head, Neck and Lung Cancers

Moderator: Dr. Johnson

• Emerging Agents in the Multimodal Management of Head, Neck, and Thyroid Cancers

  Robert I. Haddad MD

• NSCLC and SCLC: Molecular Testing and Emerging Treatment Options

  Bruce E. Johnson MD

• Session Break

Melanoma Cancer

Track Leader: Dr. Johnson

• Evidence-Based Treatment Approaches for Adjuvant, Advanced, and Metastatic Melanoma

  F. Stephen Hodi MD

• Panel Discussion

  All Faculty

• Closing Remarks

Genitourinary Cancer

• Opening Remarks

  Robert J. Mayer MD – Course Director

Moderator: Dr. Johnson

• COVID and Cancer Treatment

  Amy C. Bessnow MD, MPH

Genitourinary Cancers

Moderator: Dr. Johnson

• Prostate Cancer: An Evolving Treatment Landscape

  William K. Oh MD

• Session Break

• Treatment Selection in Renal Cell and Urothelial Carcinoma: Integrating Novel Agents into Daily Practice

  Robert Dreicer MD

• Panel Discussion

  All Faculty

• Closing Remarks